Modafinil, a wakefulness-promoting agent primarily used to treat narcolepsy, shift work sleep disorder, and excessive daytime sleepiness associated with obstructive sleep apnea, has sparked interest beyond its approved medical uses. Its purported cognitive-enhancing effects have attracted students, professionals, and entrepreneurs alike, creating a unique financial landscape.